California reopens June 15 because cases are low and vaccinations ahead of schedule, according to California Governor Gavin Newsom. In his announcement Tuesday, April 6, Newsom confirmed that California could lift most statewide COVID-19 restrictions by June 15 if vaccine supply is sufficient and hospitalizations remain low.
For conventions, that means that when California reopens, indoor gatherings greater than 100 people will be allowed, provided that participants wear face masks. International convention attendees will be allowed only if fully vaccinated. Continue reading “California Poised to Fully Reopen June 15”
The 2021 CREF Marriott hotel reservation portal is now open, and it’s never too early to book your stay.
The four-star Marriott Marquis San Diego Marina is the official CREF 2021 hotel. Our reservation portal is now active, so remember to make your reservations early if you’re planning to attend this fall.
Wishing you a day filled with an abundance of love.
And since it’s also American Heart Month, why not enjoy the opportunity to focus on your own big, generous heart for a moment? Listen closely to what it says—and then follow it! Happy Valentine’s Day from the CREF team to you and yours.
Two Keynote Speakers Announced
Hilary P. Grocott MD
Dr. Hilary P. Grocott is Professor in the Departments of both Anesthesia & Perioperative Medicine and Surgery at University of Manitoba. He concurrently serves as Adjunct Professor of Anesthesiology at Duke University. Dr. Grocott’s primary research interest has focused on the impact of cardiopulmonary bypass on the brain. As Editor-in-Chief of the Canadian Journal of Anesthesia, Dr. Grocott oversees the annual peer review of more than 750 manuscripts in anesthesia, critical care, and pain medicine.
Linda Shore-Lesserson MD
Dr. Linda Shore-Lesserson serves as the Chief of Cardiothoracic Anesthesia, Professor of Anesthesiology, and Director of Cardiovascular Anesthesiology at Montefiore Medical Center in New York. Dr. Shore-Lesserson’s research interests include hemostasis and thrombosis as they relate to cardiovascular disease. She recently served as the lead author on an innovative joint STS / SCA / AmSECT study providing clinical practice guidelines on anticoagulation best practices for cardiopulmonary bypass surgery.
Two Keynote Speakers Announced
Robert A. Baker PhD CCP(Aus)
Professor Baker is Director of Cardiac Surgery Research & Perfusion at Flinders Medical Centre in South Australia. His research interests include blood management, practice improvement, data management, guidelines, neurocognitive effects of cardiac surgery, pharmacological interventions, postoperative outcomes, and quality-of-life outcomes. Professor Baker works locally, nationally, and internationally to achieve better outcomes for patients undergoing cardiac surgery.
Frank W. Sellke MD
Dr. Frank Sellke is the chief of cardiothoracic surgery at Rhode Island Hospital and The Miriam Hospital, and is Professor of Cardiothoracic Surgery at Brown University. His research interests include the regulation of microcirculation in health and disease, ischemic injury and inflammation during cardiac surgery, collateral vascular formation, and the use of growth factors and cell therapy to increase blood flow to ischemic tissue. Continue reading “View Our First Two Featured Speakers”
Dr. C. David Mazer Joins the CREF Team
A new CREF co-director joins the team: CREF is pleased to announce that Dr. C. David Mazer, Professor of Anesthesia and Physiology at the University of Toronto, will serve as the Co-Director of the 39th Annual Cardiothoracic Surgery Symposium. He will work alongside other Program Committee membersto shape the scientific program and create an exceptional educational experience for attendees.
“I feel honored to take on this position and look forward to contributing to the meeting, which has a reputation for quality education,” Mazer said. “We’ve already begun planning next year’s activity and are enthusiastic about the possibilities.”
About Dr. Mazer, CREF Co-Director
Dr. Mazer’s research interests include cardiac physiology and perioperative blood conservation and organ protection. He has co-authored 100+ peer-reviewed publications. These include practice guidelines and position statements related to perioperative transfusion and hemostasis from the STS, SCVA, and the CCS. Dr. Mazer was a lead investigator in the BART trial and is the principal investigator for TRICS III, a global study of transfusion triggers in cardiac surgery.